Login / Signup

Next generation live-attenuated influenza vaccine platforms.

Subhan UllahTed M Ross
Published in: Expert review of vaccines (2022)
Despite the recent efforts for universal influenza virus vaccines, there is a lack of broadly reactive antibodies' induction that can confer broad and long-lasting protection. Various strategies using live-attenuated influenza virus vaccines (LAIVs) are investigated to induce broadly reactive, durable, and cross-protective immune responses. LAIVs based on NS segment truncation prevent influenza virus infection and have shown to be effective vaccine candidates among other vaccine platforms. Although many approaches have been used for LAIVs generation, there is still a need to focus on the LAIVs development platforms to generate a universal influenza virus vaccine candidate.
Keyphrases
  • immune response
  • quality improvement
  • mass spectrometry
  • high speed